KBC Group Portfolio holdings
KBC Group is a Belgian bank and insurer, created in 1998 when the banks Kredietbank and CERA Bank merged with the insurers ABB and Fidelitas. It serves private clients and small and medium-sized businesses in Belgium, Bulgaria, the Czech Republic, Hungary and Slovakia, selling banking and insurance side by side. Its push into Central and Eastern Europe began in 1999 with the purchase of ČSOB, a bank serving the Czech Republic and Slovakia. In 2005 the holding company formed in the 1998 merger combined with its parent, Almanij, to become KBC Group, which added a network of European private banks. Among its main shareholders is KBC Ancora, a listed company controlled by Cera, the holding company set up by CERA Bank's cooperative clients at the time of the 1998 merger.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$207M |
| 2 |
Walmart Inc
WMT
|
+$203M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$168M |
| 4 |
Tesla
TSLA
|
+$153M |
| 5 |
Palo Alto Networks
PANW
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$261M |
| 2 |
NVIDIA
NVDA
|
+$252M |
| 3 |
Lam Research
LRCX
|
+$237M |
| 4 |
Apple
AAPL
|
+$228M |
| 5 |
UnitedHealth
UNH
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.73% |
| 2 | Financials | 11.85% |
| 3 | Communication Services | 11.01% |
| 4 | Healthcare | 10.37% |
| 5 | Consumer Discretionary | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
976
Axalta
AXTA
$7.83B
| $225K | ﹤0.01% |
6,997
+1,238
| +21% | +$42.8K |
2023 Q3
12 quarters
|
|
977
Kinsale Capital Group
KNSL
$8.91B
| $225K | ﹤0.01% |
698
| – | – |
2023 Q3
12 quarters
|
|
978
StoneX
SNEX
$6.9B
| $225K | ﹤0.01% |
3,474
| – | – |
2022 Q2
17 quarters
|
|
979
Elastic
ESTC
$9.34B
| $223K | ﹤0.01% |
2,427
| – | – |
2019 Q3
28 quarters
|
|
980
Oscar Health
OSCR
$9.6B
| $222K | ﹤0.01% |
7,212
| – | – |
2024 Q1
10 quarters
|
|
981
Vaxcyte
PCVX
$10B
| $222K | ﹤0.01% |
3,898
| – | – |
2023 Q3
12 quarters
|
|
982
Protagonist Therapeutics
PTGX
$8.55B
| $222K | ﹤0.01% |
1,574
| – | – |
2024 Q1
10 quarters
|
|
983
PBF Energy
PBF
$8.45B
| $219K | ﹤0.01% |
2,844
| – | – |
2023 Q3
12 quarters
|
|
984
Qfin Holdings
QFIN
$646M
| $219K | ﹤0.01% |
32,671
-64,690
| -66% | -$726K |
2024 Q3
8 quarters
|
|
985
Federal Signal
FSS
$7.04B
| $218K | ﹤0.01% |
1,965
+332
| +20% | +$39.7K |
2019 Q2
29 quarters
|
|
986
OneMain Financial
OMF
$6.34B
| $218K | ﹤0.01% |
3,938
| – | – |
2023 Q3
12 quarters
|
|
987
STAG Industrial
STAG
$7.13B
| $216K | ﹤0.01% |
6,043
| – | – |
2023 Q3
12 quarters
|
|
988
DELISTED
Arcosa
ACA
| $215K | ﹤0.01% |
1,472
| – | – |
2018 Q4
31 quarters
|
|
989
The Mosaic Company
MOS
$6.97B
| $215K | ﹤0.01% |
9,918
| – | – |
2013 Q2
53 quarters
|
|
990
Aurora
AUR
$8.51B
| $213K | ﹤0.01% |
38,452
| – | – |
2023 Q3
12 quarters
|
|
991
HealthEquity
HQY
$8.56B
| $213K | ﹤0.01% |
2,411
| – | – |
2023 Q3
12 quarters
|
|
992
Bilibili
BILI
$5.3B
| $212K | ﹤0.01% |
14,146
| – | – |
2019 Q1
30 quarters
|
|
993
Procore
PCOR
$11.6B
| $212K | ﹤0.01% |
4,090
+1,005
| +33% | +$53K |
2023 Q3
12 quarters
|
|
994
Hims & Hers Health
HIMS
$4.62B
| $211K | ﹤0.01% |
7,067
+1,465
| +26% | +$45K |
2024 Q2
9 quarters
|
|
995
Macy's
M
$6.45B
| $211K | ﹤0.01% |
9,256
| – | – |
2023 Q3
12 quarters
|
|
996
Robert Half
RHI
$4.3B
| $211K | ﹤0.01% |
5,748
-1,119
| -16% | -$44.2K |
2013 Q2
53 quarters
|
|
997
Ionis Pharmaceuticals
IONS
$4.84B
| $210K | ﹤0.01% |
4,699
-46,428
| -91% | -$2.64M |
2015 Q1
46 quarters
|
|
998
Varonis Systems
VRNS
$5.64B
| $210K | ﹤0.01% |
4,432
-536
| -11% | -$24K |
2023 Q3
12 quarters
|
|
999
Lithia Motors
LAD
$6.41B
| $209K | ﹤0.01% |
716
| – | – |
2023 Q3
12 quarters
|
|
1000
Noble Corp
NE
$6.97B
| $209K | ﹤0.01% |
5,010
+1,175
| +31% | +$50.7K |
2023 Q3
12 quarters
|
|
Similar funds
KBC Group's Q3 2026 Portfolio in Review
As of Q3 2026, KBC Group held 1,901 positions worth $47.9B, up 3.4% from $46.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
KBC Group's Q3 2026 filing shows 57 new, 602 increased, 322 reduced and 75 closed positions. Its largest new stake was News Corp Class B: 24,514 shares worth $778K. The largest sale was JPMorgan Chase, an estimated $261M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 40% a quarter earlier, followed by Financials and Communication Services.
- KBC Group's largest Q3 2026 buy was News Corp Class B: 24,514 shares worth $778K.
- KBC Group added most to Advanced Micro Devices in Q3 2026, an estimated $207M increase.
- KBC Group's biggest Q3 2026 reduction was JPMorgan Chase, cutting an estimated $261M.
- KBC Group fully exited Electronic Arts in Q3 2026, selling an estimated $67.9M.
- KBC Group's ten largest holdings make up 38% of its $47.9B portfolio in Q3 2026.
- KBC Group opened 57 new positions and closed 75 in Q3 2026.
- KBC Group's portfolio value rose 3.4% quarter-over-quarter to $47.9B.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.